Looks like you clickedhttps://cllsociety.org/2020/01/iwcll-2019-dr-danielle-brander-on-bendamustine-and-rituxan-br-versus-ibrutinib-based-therapies-for-frontline-treatment-of-chronic-lymphocytic-leukemia-cll-in-elderly-patients/
If you do not want to visit that page, you can close this browser tab.
